1-((2R,3R,4S,5R)-5-((S)-((2S,3S,4S)-2-amino-5-(carbamoyloxy)-3,4-dihydroxypentanamido)(carboxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid; 5-[[2-Amino-5-O-(aminocarbonyl)-2-deoxy-L-xylonoyl]amino]-1-(5-carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,5-dideoxy-?-D-allofuranuronic Acid; Polyoxin D; Polyoxorim; 5-?[[2-?Amino-?5-?O-?(aminocarbonyl)?-?2-?deoxy-?L-?xylonoyl]?amino]?-?1-?(5-?carboxy-?3,?4-?dihydro-?2,?4-?dioxo-?1(2H)?-?pyrimidinyl)?-?1,?5-?dideoxy-?-?D-?allofuranuronic Acid
Polyoxin D is a fully characterized chemical compound used as a reference standard of API Polyoxin. The standard offered is compliant with regulatory guidelines. Polyoxin D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 22976-86-9
